Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
Completed · Phase 2 · Has a placebo group
Conditions studied: Pain
In brief
The primary objective of this trial is to evaluate analgesic efficacy of Fentanyl Sublingual Spray compared with placebo in participants with postoperative pain after a bunionectomy.
Key facts
- Study ID
- NCT02915978
- Run by
- INSYS Therapeutics Inc
- People needed
- 45
- Starts
- 2016-12-01
- Expected to finish
- 2017-02-10
- Last updated by the study team
- 2018-02-14
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meets protocol-specified criteria for qualification and contraception
- Willing and able to remain confined in the study unit for the entire duration of each treatment period and comply with restrictions related to food, drink and medications
- Voluntarily consents to participate and provides written informed consent prior to any protocol-specific procedures
You may not qualify if…
- History or current use of over-the-counter medications, dietary supplements, or drugs (including nicotine and alcohol) outside protocol-specified parameters
- Signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise:
- the safety or well-being of the participant or study staff;
- the safety or well-being of the participant's offspring (such as through pregnancy or breast-feeding);
- the analysis of results
Where it is running
- Arizona Research Center — Phoenix, Arizona, United States
- Anaheim Clinical Trials — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.